NCT05159492View on ClinicalTrials.gov

Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF)

NACompletedINTERVENTIONAL

Enrollment

292

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

February 14, 2025

Study Completion Date

February 14, 2025

Conditions

Atrial Fibrillation

Interventions

DEVICE

PVI using PEF

DEVICE

PVI using CFRF

Trial Locations (9)

Unknown

Medical University of Graz, Graz

AZ Sint-Jan Brugge-Oostende, Bruges

Homolka Hospital, Prague

Institute for Clinical and Experimental Medicine, Prague

CHU Bordeaux, Pessac

CHU Toulouse, Toulouse

Clinique Pasteur, Toulouse, Toulouse

Cardiovascular Center Bad Neustadt, Bad Neustadt an der Saale

Deutsches Herzzentrum München, Munich

All Listed Sponsors

collaborator

Horizon 2020 - European Commission

OTHER

lead

University Hospital, Bordeaux

OTHER

NCT05159492 - Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF) | Biotech Hunter | Biotech Hunter